PHARMA ingredients may represent just 4% of Kerry Group’s business, but they can play a useful role in the company’s global expansion strategy, according to an equity report by Davy stockbrokers.

INNOVATION and new products in every sector from food ingredients, bakery, soft drinks and syrups were central to the 2010 sales growth of 9.7% to €5 billion unveiled by Kerry Group.